Elevate Uranium Ltd (EL8.AX)
West Perth, WA, AU
Headquartered in West Perth, Australia, Elevate Uranium Ltd focuses on the exploration and evaluation of uranium reserves, a business it has pursued since its incorporation in 1978. The company's key operations are distributed across two main regions: Namibia, where it manages projects like Koppies, Hirabeb, Marenica, and Namib IV; and Australia. In Australia, Elevate Uranium fully owns the Angela, Thatcher Soak, Oobagooma, and Minerva project areas, and participates in joint ventures including Bigrlyi, Malawiri, Walbiri, and Areva. The entity adopted its present name, Elevate Uranium Ltd, in May 2021, having previously been known as Marenica Energy Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.26% | -3.92% | -10.91% | -33.78% | -14.04% | -19.67% | -14.04% | -15.52% | -25.76% | +8.89% | -99.74% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Uranium: +0.0%+422,151.7% ★
-
EPS growth Uranium: +2.0%+4.4% ★ Q4'25: -93.7% (vs Q4'23)
-
FCF margin FCF growth · Uranium: +20.0%-1,623.3%
-
EBIT margin Uranium: +0.0%-1,567.0%
-
ROIC Uranium: -3.7%-462.4% Q4'25: -348.6% (vs Q4'23)
-
Share dilution Uranium: -7.0%+19.8% Q4'25: +45.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Uranium: -0.04×-0.04× Q4'25: -0.01× (vs Q4'23)
| Metric |
Jun 2026 1 Rev. Ana. |
Jun 2027 1 Rev. Ana. |
Jun 2028 1 Rev. Ana. |
|---|---|---|---|
| Revenue |
300.0K
300.0K – 300.0K
|
300.0K
300.0K – 300.0K
+0.0% YoY
|
300.0K
300.0K – 300.0K
+0.0% YoY
|
| EBITDA |
60.0K
60.0K – 60.0K
|
60.0K
60.0K – 60.0K
+0.0% YoY
|
60.0K
60.0K – 60.0K
+0.0% YoY
|
| EBIT |
60.0K
60.0K – 60.0K
|
60.0K
60.0K – 60.0K
+0.0% YoY
|
60.0K
60.0K – 60.0K
+0.0% YoY
|
| Net Income |
—
— – —
|
—
— – —
|
—
— – —
|
| SGA |
3.42B
3.42B – 3.42B
|
3.42B
3.42B – 3.42B
+0.0% YoY
|
3.42B
3.42B – 3.42B
+0.0% YoY
|
| EPS |
—
— – —
|
—
— – —
|
—
— – —
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-25 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-15 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-14 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-13 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-12 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-11 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Sprott Junior Uranium Miners ETF URNJ | 0.80% | 2.63M | 0.80% |
| 2 | BetaShares - Global Uranium ETF URNM.AX | 0.32% | 722.1K | 0.69% |
| 3 | Global X - Uranium UCITS ETF URNU.L | 0.10% | 621.5K | 0.65% |
| 4 | Global X - Uranium ETF URA | 0.07% | 4.42M | 0.69% |
| 5 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 12.6K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Murray Philip Hill Fausimm | MD, Chief Executive Officer & Executive Director | 415.5K | male |
| Shane McBride FCIS FCPA FGIA MAICD | Chief Financial Officer & Company Secretary | 368.4K | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EL8.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
